Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neurology. Genetics

Showing results (451-460 of 842) with videos related to

Pageof 85
Sort By:
Neurology. Genetics|February 12, 2020
Defining and expanding the phenotype of <i>QARS</i>-associated developmental epileptic encephalopathyKatrine M Johannesen, Diana Mitter, Robert Janowski, et al.
Neurology. Genetics|February 12, 2020
Spastic paraplegia due to recessive or dominant mutations in <i>ERLIN2</i> can convert to ALSMaria-Del-Mar Amador, François Muratet, Elisa Teyssou, et al.
Neurology. Genetics|February 12, 2020
HSAN-VI: A spectrum disorder based on dystonin isoform expressionAnisha Lynch-Godrei, Rashmi Kothary
Neurology. Genetics|February 12, 2020
Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohortJennifer Roggenbuck, Marilly Palettas, Leah Vicini, et al.
Neurology. Genetics|February 12, 2020
Deep sequencing of mitochondrial DNA and characterization of a novel <i>POLG</i> mutation in a patient with arPEOCarola Hedberg-Oldfors, Bertil Macao, Swaraj Basu, et al.
Neurology. Genetics|November 23, 2020
Disease duration in autosomal dominant familial Alzheimer disease: A survival analysisIvanna M Pavisic, Jennifer M Nicholas, Antoinette O'Connor, et al.
Neurology. Genetics|November 2, 2020
Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespanKristine B Walhovd, Anders M Fjell, Øystein Sørensen, et al.
Neurology. Genetics|November 2, 2020
Novel dominant MPAN family with a complex genetic architecture as a basis for phenotypic variabilityPeter Balicza, Renata Bencsik, Andras Lengyel, et al.
Neurology. Genetics|November 2, 2020
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer diseaseYoung Ho Park, Angela Hodges, Andrew Simmons, et al.
Neurology. Genetics|November 2, 2020
Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by <i>POLR3A</i> mutationsVanessa Zanette, Aurelio Reyes, Mark Johnson, et al.
Pageof 85

Showing results (451-460 of 842) with videos related to

Sort By:
Pageof 85
Neurology. Genetics|February 12, 2020
Defining and expanding the phenotype of <i>QARS</i>-associated developmental epileptic encephalopathyKatrine M Johannesen, Diana Mitter, Robert Janowski, et al.
Neurology. Genetics|February 12, 2020
Spastic paraplegia due to recessive or dominant mutations in <i>ERLIN2</i> can convert to ALSMaria-Del-Mar Amador, François Muratet, Elisa Teyssou, et al.
Neurology. Genetics|February 12, 2020
HSAN-VI: A spectrum disorder based on dystonin isoform expressionAnisha Lynch-Godrei, Rashmi Kothary
Neurology. Genetics|February 12, 2020
Incidence of pathogenic, likely pathogenic, and uncertain ALS variants in a clinic cohortJennifer Roggenbuck, Marilly Palettas, Leah Vicini, et al.
Neurology. Genetics|February 12, 2020
Deep sequencing of mitochondrial DNA and characterization of a novel <i>POLG</i> mutation in a patient with arPEOCarola Hedberg-Oldfors, Bertil Macao, Swaraj Basu, et al.
Neurology. Genetics|November 23, 2020
Disease duration in autosomal dominant familial Alzheimer disease: A survival analysisIvanna M Pavisic, Jennifer M Nicholas, Antoinette O'Connor, et al.
Neurology. Genetics|November 2, 2020
Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespanKristine B Walhovd, Anders M Fjell, Øystein Sørensen, et al.
Neurology. Genetics|November 2, 2020
Novel dominant MPAN family with a complex genetic architecture as a basis for phenotypic variabilityPeter Balicza, Renata Bencsik, Andras Lengyel, et al.
Neurology. Genetics|November 2, 2020
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer diseaseYoung Ho Park, Angela Hodges, Andrew Simmons, et al.
Neurology. Genetics|November 2, 2020
Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by <i>POLR3A</i> mutationsVanessa Zanette, Aurelio Reyes, Mark Johnson, et al.
Pageof 85